ArticleFrontiers in neurology2025
Familial prevalence of psoriasis in patients with multiple sclerosis - results from an Australian survey.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The familial association of psoriasis with multiple sclerosis (MS) has been observed in several international studies. Whether this link is applicable in an Australian setting has yet to be established. The aim of this study was to evaluate the prevalence of psoriasis in family members of an MS cohort in the Australian population. Methods: A survey study of adult MS patients was conducted between 2018 and 2021 at the MS clinic, Royal North Shore Hospital, Sydney, Australia. Results: A total of 204 MS participants, with mean age of 48.8 years, were included in the study. Of these participants, 67 were male (32.8%) and 137 were female (67.2%). An increased rate of psoriasis was found among family members of MS patients: 35 (17.2%) MS patients had family history of psoriasis, and 11 patients reported a history of psoriasis themselves. Of the 35 MS patients with family history of psoriasis, female participants were found to be at a higher risk of psoriasis (34.6%, Discussion: This study demonstrates a significantly increased risk of psoriasis among family members of MS patients, suggesting overlap in genetic risk between the two immune-mediated diseases. Further prospective research is warranted to determine the characteristics of association in MS individuals with psoriasis or/and family history of psoriasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.